3wmudrarqkswf8vzl4st logo aptagen (hq)

Aptagen, LLC

ic 7.5/10 Overall Rating 100% Positive
ic 3 Orders Completed
Jacobus, Pennsylvania, US

About Aptagen, LLC

Antibody problems? Have difficult targets to develop effective ligands or antibodies? What if an antibody doesn't exist for your target or antigen? No problem. Let Aptagen provide you with an alternative - the aptamer. You've heard about this new technology. Now, try it.

HIGH Affinity. HIGH... Show more »

Antibody problems? Have difficult targets to develop effective ligands or antibodies? What if an antibody doesn't exist for your target or antigen? No problem. Let Aptagen provide you with an alternative - the aptamer. You've heard about this new technology. Now, try it.

HIGH Affinity. HIGH Specificity. Contact Us today for details.

What is an aptamer? A stable RNA or DNA that binds with high affinity and specificity to targets such as small organics, peptides, proteins, cells, and tissues. Unlike antibodies, some aptamers exhibit stereoselectivity. In addition, aptamers have been generated that exhibit greater than 10,000-fold binding affinity for theophylline over caffeine, which differ from one another in structure by only a single methyl group.

Show less

Our Services (9)


ic

Aptamer Selection Service

Price on request

A la carte services as well as packaged pricing are available.

Phase I: Screening/Selection (2-3 months)
Iterative rounds of screening an initial random library against a target for positive selection, and counter-selection against a counter-target for specificity.
Client Materials: Please note that the Client will need to... Show more »

A la carte services as well as packaged pricing are available.

Phase I: Screening/Selection (2-3 months)
Iterative rounds of screening an initial random library against a target for positive selection, and counter-selection against a counter-target for specificity.
Client Materials: Please note that the Client will need to provide the target(s) for Aptagen. It is highly recommended that counter-target(s) is also provided for enrichment of highly specific apta-sensors. 10 nmoles of material is typically sufficient. A Material Acquisition Form must be completed for background information on the target, any associated hazards, and handling requirements.

Phase II: Sequencing & Bioinformatics (2-3 weeks)
The enriched polyclonal pool is sequenced and thousands of apta-sensor sequences are provided. Client will have access to all the data generated from the polyclonal apta-sensor pool in Phase I (hundreds to thousands of sequences).

Phase III: Synthesis of Candidates (1-2 weeks)
Monoclonal aptamer oligo candidate(s) are synthesized or transcribed, purified, and QC. Projects are typically based on unmodified aptamers.
Typically 3 to 5 candidates are prepared to be analyzed in Phase IV below.

Phase IV: Validation (1 month)
Each tested for assessing Kd affinities, signal-to-background, LOD, targeting, or EC50/IC50, etc.
Assay Choices: SPR or BLI (ForteBio), Calorimetry (ITC), Thermophoresis, Dot Blot, Gel-shift assay, ELONA (ELISA), Microscopy, Flow Cytometry, or Imaging, etc.

Phase V: Optimization (~1 month)
At the Client’s discretion, Aptagen may ‘multimerize’ aptamers to further enhance functional properties of aptamer candidate(s) and/or truncate or minimize the length of the oligo to reduce large-scale manufacturing costs and processing time downstream. Aptagen’s proprietary in silico algorithm searches and explores ‘sequence space’.
Inquire. Project specific. The Optimization Phase may not be necessary for research purposes. This phase entails truncation of aptamer oligos to reduce production costs for commercialization or ‘multimerization' of aptamers to further increase affinity/avidity. This Phase may trigger only if Client believes Optimization a) is cost effective to minimize production costs while maximizing activity for large-scale commercial use and/or, b) widens the claims in Client's IP to strengthen the coverage of all possible aptamer sequence variants.
Inquire about the apta-beacon™ technology to eliminate antibody-based ELISAs with the advantage of: “No Capturing, No Washing, Just READ”™

Show less
Illumina MiniSeq PCR thermal cycler Next Generation Sequencing SDS-PAGE Native PAGE SELEX RNA DNA Biology protein Lipid Small Organic Molecule Cells Show 13 more tags Show less

ic

Aptamer Screening

Price on request

A la carte services as well as packaged pricing are available.

Phase I: Screening/Selection (2-3 months)
Iterative rounds of screening an initial random library against a target for positive selection, and counter-selection against a counter-target for specificity.
Client Materials: Please note that the Client will need to... Show more »

A la carte services as well as packaged pricing are available.

Phase I: Screening/Selection (2-3 months)
Iterative rounds of screening an initial random library against a target for positive selection, and counter-selection against a counter-target for specificity.
Client Materials: Please note that the Client will need to provide the target(s) for Aptagen. It is highly recommended that counter-target(s) is also provided for enrichment of highly specific apta-sensors. 10 nmoles of material is typically sufficient. A Material Acquisition Form must be completed for background information on the target, any associated hazards, and handling requirements.

Phase II: Sequencing & Bioinformatics (2-3 weeks)
The enriched polyclonal pool is sequenced and thousands of apta-sensor sequences are provided. Client will have access to all the data generated from the polyclonal apta-sensor pool in Phase I (hundreds to thousands of sequences).

Phase III: Synthesis of Candidates (1-2 weeks)
Monoclonal aptamer oligo candidate(s) are synthesized or transcribed, purified, and QC. Projects are typically based on unmodified aptamers.
Typically 3 to 5 candidates are prepared to be analyzed in Phase IV below.

Phase IV: Validation (1 month)
Each tested for assessing Kd affinities, signal-to-background, LOD, targeting, or EC50/IC50, etc.
Assay Choices: SPR or BLI (ForteBio), Calorimetry (ITC), Thermophoresis, Dot Blot, Gel-shift assay, ELONA (ELISA), Microscopy, Flow Cytometry, or Imaging, etc.

Phase V: Optimization (~1 month)
At the Client’s discretion, Aptagen may ‘multimerize’ aptamers to further enhance functional properties of aptamer candidate(s) and/or truncate or minimize the length of the oligo to reduce large-scale manufacturing costs and processing time downstream. Aptagen’s proprietary in silico algorithm searches and explores ‘sequence space’.
Inquire. Project specific. The Optimization Phase may not be necessary for research purposes. This phase entails truncation of aptamer oligos to reduce production costs for commercialization or ‘multimerization' of aptamers to further increase affinity/avidity. This Phase may trigger only if Client believes Optimization a) is cost effective to minimize production costs while maximizing activity for large-scale commercial use and/or, b) widens the claims in Client's IP to strengthen the coverage of all possible aptamer sequence variants.
Inquire about the apta-beacon™ technology to eliminate antibody-based ELISAs with the advantage of: “No Capturing, No Washing, Just READ”™

Show less
Illumina MiniSeq PCR thermal cycler Next Generation Sequencing SDS-PAGE Native PAGE SELEX RNA DNA Biology protein Lipid Small Organic Molecule Cells Show 13 more tags Show less

ic

Aptamers

Price on request

A la carte services as well as packaged pricing are available.

Phase I: Screening/Selection (2-3 months)
Iterative rounds of screening an initial random library against a target for positive selection, and counter-selection against a counter-target for specificity.
Client Materials: Please note that the Client will need to... Show more »

A la carte services as well as packaged pricing are available.

Phase I: Screening/Selection (2-3 months)
Iterative rounds of screening an initial random library against a target for positive selection, and counter-selection against a counter-target for specificity.
Client Materials: Please note that the Client will need to provide the target(s) for Aptagen. It is highly recommended that counter-target(s) is also provided for enrichment of highly specific apta-sensors. 10 nmoles of material is typically sufficient. A Material Acquisition Form must be completed for background information on the target, any associated hazards, and handling requirements.

Phase II: Sequencing & Bioinformatics (2-3 weeks)
The enriched polyclonal pool is sequenced and thousands of apta-sensor sequences are provided. Client will have access to all the data generated from the polyclonal apta-sensor pool in Phase I (hundreds to thousands of sequences).

Phase III: Synthesis of Candidates (1-2 weeks)
Monoclonal aptamer oligo candidate(s) are synthesized or transcribed, purified, and QC. Projects are typically based on unmodified aptamers.
Typically 3 to 5 candidates are prepared to be analyzed in Phase IV below.

Phase IV: Validation (1 month)
Each tested for assessing Kd affinities, signal-to-background, LOD, targeting, or EC50/IC50, etc.
Assay Choices: SPR or BLI (ForteBio), Calorimetry (ITC), Thermophoresis, Dot Blot, Gel-shift assay, ELONA (ELISA), Microscopy, Flow Cytometry, or Imaging, etc.

Phase V: Optimization (~1 month)
At the Client’s discretion, Aptagen may ‘multimerize’ aptamers to further enhance functional properties of aptamer candidate(s) and/or truncate or minimize the length of the oligo to reduce large-scale manufacturing costs and processing time downstream. Aptagen’s proprietary in silico algorithm searches and explores ‘sequence space’.
Inquire. Project specific. The Optimization Phase may not be necessary for research purposes. This phase entails truncation of aptamer oligos to reduce production costs for commercialization or ‘multimerization' of aptamers to further increase affinity/avidity. This Phase may trigger only if Client believes Optimization a) is cost effective to minimize production costs while maximizing activity for large-scale commercial use and/or, b) widens the claims in Client's IP to strengthen the coverage of all possible aptamer sequence variants.
Inquire about the apta-beacon™ technology to eliminate antibody-based ELISAs with the advantage of: “No Capturing, No Washing, Just READ”™

Show less
Illumina MiniSeq PCR thermal cycler Next Generation Sequencing SDS-PAGE Native PAGE SELEX RNA DNA Biology protein Lipid Small Organic Molecule Cells Show 13 more tags Show less

ic

mRNA Display

Price on request
Request a quote for more information about this service.

ic

Biopharmaceutical Consulting

Starting at $500.00 per hour

If Client desires to perform the aptamer research and development work themselves in whole or in part, Aptagen is able to provide consultation services at rate of $500/hr. The do-it-yourself (DIY) option also includes protocols and standard operating procedures (SOPs) to easily perform the experiments in your... Show more »

If Client desires to perform the aptamer research and development work themselves in whole or in part, Aptagen is able to provide consultation services at rate of $500/hr. The do-it-yourself (DIY) option also includes protocols and standard operating procedures (SOPs) to easily perform the experiments in your lab. Messaging and phone support included.

A 10 hr. minimum for consulting service is required.

Show less
SELEX RNA DNA Biology protein Lipid Small Organic Molecule Cells Show 8 more tags Show less

ic

Project Management

Starting at $500.00 per hour

If Client desires to perform the aptamer research and development work themselves in whole or in part, Aptagen is able to provide consultation services at rate of $500/hr. The do-it-yourself (DIY) option also includes protocols and standard operating procedures (SOPs) to easily perform the experiments in your lab. Messaging and... Show more »

If Client desires to perform the aptamer research and development work themselves in whole or in part, Aptagen is able to provide consultation services at rate of $500/hr. The do-it-yourself (DIY) option also includes protocols and standard operating procedures (SOPs) to easily perform the experiments in your lab. Messaging and phone support included.

A 10 hr. minimum for consulting service is required.

Show less
SELEX RNA DNA Biology protein Lipid Small Organic Molecule Cells Show 8 more tags Show less

ic

Aptamer Modification

Price on request

Estimated timeline: 1 month

At the Client’s discretion, Aptagen may ‘multimerize’ aptamers to further enhance functional properties of aptamer candidate(s) and/or truncate or minimize the length of the oligo to reduce large-scale manufacturing costs and processing time downstream. Aptagen’s proprietary in silico algorithm... Show more »

Estimated timeline: 1 month

At the Client’s discretion, Aptagen may ‘multimerize’ aptamers to further enhance functional properties of aptamer candidate(s) and/or truncate or minimize the length of the oligo to reduce large-scale manufacturing costs and processing time downstream. Aptagen’s proprietary in silico algorithm searches and explores ‘sequence space’.

Inquire. Project specific. The Optimization Phase may not be necessary for research purposes. This phase entails truncation of aptamer oligos to reduce production costs for commercialization or ‘multimerization' of aptamers to further increase affinity/avidity. This Phase may trigger only if Client believes Optimization a) is cost effective to minimize production costs while maximizing activity for large-scale commercial use and/or, b) widens the claims in Client's IP to strengthen the coverage of all possible aptamer sequence variants.

Inquire about the apta-beacon™ technology to eliminate antibody-based ELISAs with the advantage of: “No Capturing, No Washing, Just READ”™

Show less

ic

Drug Discovery & Development

Price on request

Drug Discovery & Development Services

Drug Discovery & Development Services

Show less

ic

Drug Development

Price on request

Drug Development Services

Drug Development Services

Show less

Not finding what you're looking for?

Get info on this provider's capabilities without requesting a quote.
Missing Avatar

James Benson

Project Manager
Missing Avatar

Albert Liao

Lab Director
FileType/PDF Created with Sketch.

60308_Aptamers_NoBleed.pdf

FileType/PDF Created with Sketch.

AptaBeacon Flyer ah062016.pdf

FileType/PDF Created with Sketch.

ARTICLE INSERT (Bio-Processing - Synthetic Antibodies).pdf

FileType/Other Created with Sketch.

dice_flyer.png

Aptagen, LLC has not received any endorsements.